Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study

Thomas Skovhus Prior, Thomas Troelsen, Ole Hilberg, Thomas Skovhus Prior, Thomas Troelsen, Ole Hilberg

Abstract

Introduction: Cognitive deficits in patients suffering from chronic obstructive pulmonary disease (COPD) have been described and hypoxaemia has been addressed as a possible cause. Cognitive functions in patients with interstitial lung disease (ILD) are not well studied. These patients are taking part in everyday traffic, but little is known regarding their driving performance. This study was conducted to determine the driving performance in patients with COPD and ILD, respectively compared to healthy controls using a driving simulator. Additionally, the effect of oxygen supply was addressed.

Methods: 16 patients with COPD (8 receivers and 8 non-receivers of long-term oxygen therapy (LTOT)), 8 patients with ILD (consisting of idiopathic interstitial pneumonias) and 8 healthy controls were tested in a driving simulator. Each test lasted 45 min. In the oxygen intervention part of the study the patients were randomised to receive oxygen therapy in the first or second test and acted as their own controls.

Results: Patients with COPD had significantly impaired driving performance when comparing SD from the centre of the road and number of off-road events to controls. Patients with COPD receiving LTOT performed significantly worse than those not receiving LTOT when comparing SD and worse than the patients with ILD when comparing SD and off-road events. Patients with ILD performed similarly to controls (SD: LTOT 2.39*; no LTOT 0.69*; ILD 0.37; controls 0.36; *p<0.05. Off-road: LTOT 226.67*; no LTOT 78.92*; ILD 40.00; controls 25.78; *p<0.05). Oxygen therapy had no effect on driving performance.

Conclusions: Patients with ILD performed similarly to controls in the driving simulator, whereas patients with COPD showed decreased driving performance, especially those receiving LTOT. Doctors should be aware of this when renewing the driving license of patients with COPD. Oxygen therapy showed no effect on driving performance.

Trial registration number: NCT02125916.

Keywords: Ambulatory Oxygen Therapy; COPD epidemiology; Interstitial Fibrosis; Long Term Oxygen Therapy (LTOT).

Figures

Figure 1
Figure 1
1. Controls; 2. LTOT COPD without oxygen; 3. LTOT COPD with oxygen; 4. No LTOT COPD without oxygen; 5. No LTOT COPD with oxygen; 6. ILD without oxygen; 7.ILD with oxygen. Bars depict mean values, error bars IQR. COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; LTOT, long-term oxygen supply.

References

    1. Grant I, Heaton RK, McSweeny AJ et al. . Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982;142:1470–6.
    1. Fix AJ, Golden CJ, Daughton D et al. . Neuropsychological deficits among patients with chronic obstructive pulmonary disease. Int J Neurosci 1982;16:99–105.
    1. Prigatano GP, Parsons O, Wright E et al. . Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease. J Consult Clin Psychol 1983;51:108–16.
    1. Favalli A, Miozzo A, Cossi S et al. . Differences in neuropsychological profile between healthy and COPD older persons. Int J Geriatr Psychiatry 2008;23:220–1.
    1. Liesker JJ, Postma DS, Beukema RJ et al. . Cognitive performance in patients with COPD. Respir Med 2004;98:351–6.
    1. Elfferich MD, Nelemans PJ, Ponds RW et al. . Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 2010;80:212–19.
    1. Orth M, Diekmann C, Suchan B et al. . Driving performance in patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2008;59(Suppl 6):539–47.
    1. Pretto JJ, McDonald CF. Acute oxygen therapy does not improve cognitive and driving performance in hypoxaemic COPD. Respirology 2008;13:1039–44.
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442
    1. Land M, Horwood J. Which parts of the road guide steering? Nature 1995;377:339–40.
    1. Wilson DK, Kaplan RM, Timms RM et al. . Acute effects of oxygen treatment upon information processing in hypoxemic COPD patients. Chest 1985;88:239–43.
    1. Sung EJ, Min BC, Kim SC et al. . Effects of oxygen concentrations on driver fatigue during simulated driving. Appl Ergon 2005;36:25–31.
    1. Karakontaki F, Gennimata SA, Palamidas AF et al. . Driving-related neuropsychological performance in stable COPD patients. Pulm Med 2013;2013:297371
    1. Report of The National Chronic Obstructive Pulmonary Disease Audit 2008: clinical audit of COPD exacerbations admitted to acute NHS units across the UK, Royal College of Physicians of London, British Thoracic Society and British Lung Foundation 2008:1–81. (accessed 12 May 2015).
    1. Aleman A, Muller M, de Haan EH et al. . Vascular risk factors and cognitive function in a sample of independently living men. Neurobiol Aging 2005;26:485–90.
    1. Incalzi RA, Gemma A, Marra C et al. . Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 1993;148:418–24.
    1. Incalzi RA, Gemma A, Marra C et al. . Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest 1997;112:1506–13.
    1. Parekh PI, Blumenthal JA, Babyak MA et al. . Gas exchange and exercise capacity affect neurocognitive performance in patients with lung disease. Psychosom Med 2005;67:425–32.
    1. Grant I, Prigatano GP, Heaton RK et al. . Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry 1987;44:999–1006.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅